Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179306 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210428 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211982 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 211988 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211992 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-12-14 | 2024-02-01 | 213371 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-06-07 | 2024-07-26 | 229954 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-07-04 | 2024-09-05 | 232226 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-07-18 | 2024-11-14 | 233267 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-09-05 | 2024-09-19 | 236813 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-10-11 | 2024-11-01 | 240049 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-11-08 | 2024-11-21 | 242367 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2025-01-30 | 2025-03-20 | 249204 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2025-06-05 | 2025-07-03 | 259701 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2025-11-13 | 2025-11-13 | 271793 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2025-11-20 | 2025-12-04 | 272304 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2019-10-17 | 2020-03-26 | 96720 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2022-12-01 | 2022-12-15 | 176785 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2024-11-21 | 2025-02-06 | 243583 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2019-11-28 | 2020-03-05 | 99941 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258433 |
| TEVA-PAROXETINE | 10MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258436 |
| TEVA-PINDOLOL | 10MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258459 |
| TEVA-PINDOLOL | 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258544 |
| TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
| TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Discontinued | 2025-09-02 | 2025-09-02 | 266353 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253171 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253174 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253177 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258516 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258519 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258528 |
| TEVA-PREDNISONE | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81376 |